Login to Your Account



BMS Gets Fibrosis Program in Potential $475M Amira Buy

By Jennifer Boggs


Monday, July 25, 2011
For the second time this month, Bristol-Myers Squibb Co. is placing a bet on an early clinical program.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription